rcca-header
Clinical Trials

“Phase I study of single-agent and combined checkpoint inhibition after allogeneic hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

Type of Cancer
Hematological Malignancies
Phase
Division (Location)
Hackensack, NJ
Study ID
NCT#
Brief Description
“Phase I study of single-agent and combined checkpoint inhibition after allogeneic hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.